Single Cell Transcriptomic Characterization of the Immune Microenvironment in Naturally Progressing Chronic Lymphocytic Leukemia (CLL)

被引：1
|
作者：
Purroy, Noelia [1 ,2 ,3 ]
Fan, Jean [4 ,5 ]
Li, Shuqiang [3 ]
Rassenti, Laura Z. [6 ]
Lederer, James A. [2 ,7 ]
Neuberg, Donna S. [8 ]
Kipps, Thomas J. [6 ]
Kharchenko, Peter [5 ]
Wu, Catherine J. [1 ,2 ,3 ,9 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Broad Inst, Cambridge, MA USA
[4] Harvard Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA
[5] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA
[6] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[7] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA
[8] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[9] Brigham & Womens Hosp, Dept Med, Div Hematol, 75 Francis St, Boston, MA 02115 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-110931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3112
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Molecular genetics in chronic lymphocytic leukemia (CLL)
    Chena, C
    Pedrazzini, E
    Sarmiento, M
    Arrosagaray, G
    Bengio, R
    Slavutsky, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 66 - 66
  • [42] Advances in the treatment of chronic lymphocytic leukemia (CLL)
    Lechner, K
    Jager, U
    Geissler, K
    Greinix, H
    Kalhs, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1998, 110 (20) : 701 - 708
  • [43] The proteome landscape of Chronic Lymphocytic Leukemia (CLL)
    Meier-Abt, F.
    Lu, J.
    Nanni, P.
    Collins, B.
    Xue, P.
    Gwerder, M.
    Roiss, M.
    Huellein, J.
    Oakes, C.
    Dietrich, S.
    Huber, W.
    Aebersold, R.
    Zenz, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 69 - 70
  • [44] Prognostic features in chronic lymphocytic leukemia (CLL).
    Faria, JR
    Oliveira, JRS
    Silva, MRR
    Faria, RMD
    Kerbauy, J
    Bordin, JO
    BLOOD, 1995, 86 (10) : 3317 - 3317
  • [45] Regulation of TOSO in chronic lymphocytic leukemia (CLL)
    Frenzel, L. P.
    Schulz, A.
    Pallasch, C. P.
    Claus, R.
    Kashkar, H.
    Plass, C.
    Hallek, M.
    Wendtner, C. -M
    ONKOLOGIE, 2010, 33 : 41 - 41
  • [46] Prognostic index in chronic lymphocytic leukemia (CLL).
    Garcia-Marco, JA
    Navarro, B
    Bowen, A
    Matutes, E
    Oscier, D
    Catovsky, D
    BLOOD, 1998, 92 (10) : 515A - 515A
  • [47] More ZAP for chronic lymphocytic leukemia (CLL)
    Wiestner, A
    BLOOD, 2005, 105 (05) : 1839 - 1840
  • [48] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Pettijohn, Erin M.
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (01) : 20 - 28
  • [49] PROGNOSTIC FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    CROWLEY, JJ
    SCHILLING, RF
    CLINICAL RESEARCH, 1975, 23 (04): : A486 - A486
  • [50] The immunoglobulin genes and chronic lymphocytic leukemia (CLL)
    Tobin, G
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2005, 110 (02) : 97 - 113
12345